In 2,081 Swedish women aged 75–80 from the SUPERB cohort, metagenomic profiling revealed that 404 bacterial species were significantly associated with a novel composite Frailty Mortality Index (FMI) — a measure integrating functional, physiological, and psychological dimensions that outperformed the Charlson Comorbidity Index in predicting mortality. Lower microbial diversity, reduced gene richness, and diminished predicted functional capacity all tracked with higher frailty severity and were linked to physical decline, fall-related injuries, and mortality risk. Critically, most associations replicated in an independent Chinese cohort of 1,448 older adults, suggesting cross-continental generalizability.
This is one of the largest metagenomics studies to date specifically powered for frailty phenotyping in older adults, and its replication across ethnically distinct cohorts elevates it well above typical single-population microbiome findings. The cross-continental concordance is particularly compelling: it implies shared microbial mechanisms in frailty rather than population-specific confounders. The FMI itself represents a methodological contribution — a more biologically sensitive mortality predictor than comorbidity counts alone.
For clinical practice, microbiome diversity emerges as a potentially modifiable frailty biomarker, opening doors to probiotic, prebiotic, or dietary interventions targeting specific bacterial signatures. Key limitations include the all-female, older Scandinavian sample limiting generalizability to men or younger adults, and the observational design precluding causal inference. Whether restoring these 404 species' abundance improves frailty outcomes remains the urgent next question. This study is genuinely paradigm-shifting in frailty geroscience.
